Trial Outcomes & Findings for Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections (NCT NCT01200875)

Results Overview

Recruitment status

COMPLETED

Target enrollment

25 participants

Primary outcome timeframe

5 days following PRP injection

Results posted on

2018-08-06

Participant milestones
Measure	PRP Injection (All Patients) All patients receiving local ultrasound-guided intratendinous PRP injection at our institution between July 2010 and December 2011 were screened for eligibility to participate in the study, and 25 patients were ultimately enrolled.
Overall Study STARTED	25
Overall Study COMPLETED	25
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections

Baseline characteristics by cohort
Measure	Treatment Arm n=25 Participants All patients receiving local ultrasound-guided intratendinous PRP injection at our institution between July 2010 and December 2011 were screened for eligibility to participate in the study, and 25 patients were ultimately enrolled.
Age, Continuous	38.5 years STANDARD_DEVIATION 11.3 • n=5 Participants
Sex: Female, Male Female	19 Participants n=5 Participants
Sex: Female, Male Male	6 Participants n=5 Participants
Region of Enrollment United States	25 participants n=5 Participants

Timeframe: 5 days following PRP injection

Outcome measures
Measure	PRP Injection (All Patients) n=25 Participants All patients receiving local ultrasound-guided intratendinous PRP injection at our institution between July 2010 and December 2011 were screened for eligibility to participate in the study, and 25 patients were ultimately enrolled.
Blood Growth Factor Concentrations	1.078 IGF-1 fold-change from baseline @ 24h Interval 1.009 to 1.148

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Stanford University

Phone: (650) 721-3430